Hormonal Regulation of Glycogen Synthesis
糖原合成的激素调节
基本信息
- 批准号:7564044
- 负责人:
- 金额:$ 30.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-02-15 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AttentionAttenuatedBindingBiological AssayCatalogingCatalogsCellsCharacteristicsChimera organismCyclic AMPDataDefectDevelopmentDiabetes MellitusDiseaseEnergy MetabolismEnzymesEpidemicEvaluationFundingFutureGenesGlucoseGlycogenGlycogen Storage DiseaseHepatocyteHereditary DiseaseHormonesInsulinInsulin ResistanceInvestigationLaboratoriesLafora DiseaseLiverModelingMolecularMultienzyme ComplexesMusMuscleMuscle CellsMutationNormal CellNormal tissue morphologyPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPrimary LesionProcessProtein phosphataseProteinsRegulationRoleScaffolding ProteinSeriesSignal PathwaySmall Interfering RNASpecificityStagingStructureSurface Plasmon ResonanceSurveysUncertaintyWorkdeprivationenzyme activityglucose metabolismglycogen metabolismglycogenesisglycogenolysishormone regulationin vivoknock-downmutantoverexpressionprotein complexprotein functiontrait
项目摘要
DESCRIPTION (provided by applicant): There is little doubt that we are in the midst of a worldwide epidemic of diabetes. Insulin resistance is recognized as a characteristic trait of the disease, defined by the inability to respond to normal circulating levels of insulin. The primary lesion in this state involves defects in the nonoxidative metabolism of glucose, expressed as glycogen accumulation in muscle and liver, and may also involve changes in the branching structure of glycogen. Moreover, glycogen storage diseases involve aberrations in glycogen synthesis, degradation, branching and debranching. We have studied glycogen scaffolding proteins that target enzymes involved in glycogen metabolism, and uncovered a role in controlling glycogen debranching. In Aim 1, we will study the signaling pathways involved in glycogen debranching, focusing on the regulation of the debranching enzyme AGL. We will investigate how hormones or glucose deprivation might influence the phosphorylation state and activity of this enzyme. In Aim 2, we will evaluate how the glycogen targeting protein PTG influences glycogen metabolism via AGL. PTG can interact directly with AGL, and we will explore the regulatory significance of this interaction, evaluating the control of localization and activity in detail. Finally, in Aim 3, we will evaluate the role of a dual specificity protein phosphatase called Laforin in regulating glycogen metabolism and branching. Laforin dynamically regulates AGL along with PTG. The protein is encoded by the gene that causes Lafora's disease, a genetic disease in which unbranched glycogen accumulates, thus providing important hints into how this process is regulated in normal tissues. We will search for additional substrates of Laforin to explore other ways in which this protein regulates glycogen synthesis. Together, these approaches will allow for the evaluation of how glycogen metabolism is regulated in liver and muscle, setting the stage for future investigations into its potential role in the development of diabetes and other disorders of energy metabolism.
描述(由申请人提供):毫无疑问,我们正处于糖尿病的全球流行之中。胰岛素抵抗被认为是该疾病的特征,其定义为不能对正常循环水平的胰岛素作出反应。这种状态的原发性病变涉及葡萄糖非氧化代谢的缺陷,表现为肌肉和肝脏中的糖原积累,也可能涉及糖原分支结构的变化。此外,糖原贮积病涉及糖原合成、降解、分支和去分支中的畸变。我们已经研究了糖原支架蛋白,其靶向参与糖原代谢的酶,并揭示了在控制糖原脱支中的作用。在目标1中,我们将研究参与糖原脱支的信号通路,重点关注脱支酶AGL的调节。我们将研究激素或葡萄糖剥夺如何影响这种酶的磷酸化状态和活性。在目标2中,我们将评估糖原靶向蛋白PTG如何通过AGL影响糖原代谢。PTG可以直接与AGL相互作用,我们将探索这种相互作用的调节意义,详细评估定位和活性的控制。最后,在目标3中,我们将评估称为Laforin的双特异性蛋白磷酸酶在调节糖原代谢和分支中的作用。Laforin动态调节AGL沿着PTG。这种蛋白质由导致Lafora病的基因编码,Lafora病是一种遗传性疾病,其中无分支糖原积累,从而为正常组织中如何调节这一过程提供了重要提示。我们将寻找Laforin的其他底物,以探索这种蛋白质调节糖原合成的其他方式。总之,这些方法将允许评估糖原代谢如何在肝脏和肌肉中调节,为未来研究其在糖尿病和其他能量代谢紊乱中的潜在作用奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN R. SALTIEL其他文献
ALAN R. SALTIEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN R. SALTIEL', 18)}}的其他基金
Hormonal regulation of LDL receptor trafficking
LDL 受体运输的激素调节
- 批准号:
10491294 - 财政年份:2021
- 资助金额:
$ 30.76万 - 项目类别:
Hormonal regulation of LDL receptor trafficking
LDL 受体运输的激素调节
- 批准号:
10365256 - 财政年份:2021
- 资助金额:
$ 30.76万 - 项目类别:
Adipose tissue plasticity in health and disease
健康和疾病中的脂肪组织可塑性
- 批准号:
10201590 - 财政年份:2020
- 资助金额:
$ 30.76万 - 项目类别:
Adipose tissue plasticity in health and disease
健康和疾病中的脂肪组织可塑性
- 批准号:
10617185 - 财政年份:2020
- 资助金额:
$ 30.76万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 30.76万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 30.76万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 30.76万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 30.76万 - 项目类别:
Idea to Innovation














{{item.name}}会员




